Last10K.com

Genetic Technologies Ltd (GENE) SEC Filing 20-F Annual Report for the fiscal year ending Wednesday, June 30, 2021

Genetic Technologies Ltd

CIK: 1166272 Ticker: GENE

View differences made from one year to another to evaluate Genetic Technologies Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Genetic Technologies Ltd.

Continue

Assess how Genetic Technologies Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Genetic Technologies Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Cover
Consolidated Balance Sheets
Consolidated Statement Of Cash Flows
Consolidated Statement Of Profit Or Loss And Other Comprehensive Income/(Loss)
Consolidated Statements Of Changes In Equity
Accumulated Losses
Accumulated Losses (Tables)
Auditors??? Remuneration
Auditors??? Remuneration (Tables)
Borrowing
Borrowing (Details Narrative)
Borrowing (Tables)
Capital Management
Capital Management (Details Narrative)
Cash And Cash Equivalents
Cash And Cash Equivalents (Tables)
Commitments
Commitments (Tables)
Contingent Liabilities And Contingent Assets
Contingent Liabilities And Contingent Assets (Details Narrative)
Contributed Equity
Contributed Equity (Tables)
Contributed Equity - Schedule Of Movements In Shares On Issue (Details) (Parenthetical)
Corporate Information
Cost Of Sales
Cost Of Sales (Tables)
Critical Accounting Estimates And Judgements
Financial Risk Management
Financial Risk Management (Details Narrative)
Financial Risk Management (Tables)
Foreign Exchange Movement
Impact Of Covid-19
Income Tax
Income Tax (Details Narrative)
Income Tax (Tables)
Lease Liabilities
Lease Liabilities (Details Narrative)
Lease Liabilities (Tables)
Loss Per Share
Loss Per Share (Details Narrative)
Loss Per Share (Tables)
Options
Options (Details Narrative)
Options (Tables)
Other Current Assets
Other Current Assets (Tables)
Other Gains / (Losses)
Other Gains / (Losses) (Details Narrative)
Other Gains / (Losses) (Tables)
Other Income
Other Income (Tables)
Parent Entity Financial Information
Parent Entity Financial Information (Details Narrative)
Parent Entity Financial Information (Tables)
Property, Plant And Equipment
Property, Plant And Equipment (Tables)
Provisions (Current And Non-Current)
Provisions (Current And Non-Current) (Tables)
Related Party Disclosures
Related Party Disclosures (Details Narrative)
Related Party Disclosures (Tables)
Reserves
Reserves (Tables)
Reserves - Schedule Of Reserves (Details) (Parenthetical)
Schedule Of Accumulated Losses (Details)
Schedule Of Auditor???S Remuneration (Details)
Schedule Of Borrowing (Details)
Schedule Of Capital Commitment (Details)
Schedule Of Cash And Cash Equivalents (Details)
Schedule Of Cost Of Sales (Details)
Schedule Of Current And Non-Current Provisions (Details)
Schedule Of Estimated Useful Life (Details)
Schedule Of Expenses Arising From Share-Based Payment Transactions Recognized Part Of Employee Benefit Expense (Details)
Schedule Of Expenses Relating To Leases (Details)
Schedule Of Exposure To Interest Rate Risks And Effective Interest Rates Of Financial Assets And Liabilities (Details)
Schedule Of Financial Adjustments (Details)
Schedule Of Financial Assets And Liabilities In Foreign Currencies (Details)
Schedule Of Income Tax Expense (Details)
Schedule Of Income Tax Expense (Details) (Parenthetical)
Schedule Of Independent Valuation Of Performance Rights Granted (Details)
Schedule Of Individual Financial Information (Details)
Schedule Of Issued And Paid-Up Capital (Details)
Schedule Of Maturities Of Financial Liabilities (Details)
Schedule Of Members Of Options Outstanding By Asx Code (Details)
Schedule Of Movements In Shares On Issue (Details)
Schedule Of Net Deferred Tax Assets (Details)
Schedule Of Number And Weighted Average Exercise Prices Of Share Unlisted Options (Details)
Schedule Of Number Of Options Granted Under The Plans (Details)
Schedule Of Operating Lease Expenditure Commitments (Details)
Schedule Of Option Granted And Issued (Details)
Schedule Of Option Issued And Granted (Details)
Schedule Of Other Assets (Current) (Details)
Schedule Of Other Gains / (Losses) (Details)
Schedule Of Other Gains / (Losses) (Details) (Parenthetical)
Schedule Of Other Income (Details)
Schedule Of Other Income (Details) (Parenthetical)
Schedule Of Property, Plant And Equipment (Details)
Schedule Of Reconciliation Of Movements In Property, Plant And Equipment By Asset Category (Details)
Schedule Of Reconciliation Of Provision (Details)
Schedule Of Remuneration Of Key Management Personnel (Details)
Schedule Of Reserves (Details)
Schedule Of Right-Of-Use Assets And Lease Liabilities (Details)
Schedule Of Subsidiary Undertakings (Details)
Schedule Of Tax Losses (Details)
Schedule Of Tax Losses (Details) (Parenthetical)
Schedule Of Trade And Other Payables (Details)
Schedule Of Trade And Other Receivables (Current) (Details)
Schedule Of Warrant Issued (Details)
Schedule Of Weighted Average Number Of Shares Used As Denominator (Details)
Segment Information
Segment Information (Tables)
Share Based Payments
Share Based Payments (Details Narrative)
Share Based Payments (Tables)
Subsequent Events
Subsequent Events (Details Narrative)
Subsidiaries
Subsidiaries (Tables)
Summary Of Geographical Information (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Trade And Other Payables (Current)
Trade And Other Payables (Current) (Tables)
Trade And Other Receivables (Current)
Trade And Other Receivables (Current) (Tables)
Ticker: GENE
CIK: 1166272
Form Type: 20-F Annual Report
Accession Number: 0001493152-21-021609
Submitted to the SEC: Tue Aug 31 2021 7:21:58 AM EST
Accepted by the SEC: Tue Aug 31 2021
Period: Wednesday, June 30, 2021
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/gene/0001493152-21-021609.htm